AdAlta $0.024
(0.00%)
|
High $0.03 |
Low $0.02 |
Trades 24 |
Turnover $54,432 |
Volume 2,170,184 |
| 30 June 2023 at 3:59pm | ||||
ADALTA LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (11-Nov) $6,424,338 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
Investor presentation
1AD released this announcement to the ASX on 25 May 2023, 8:27. The announcement is not marked as price sensitive, and is 27 page(s) in length and 5.15MB in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Investor presentation | 25 May 2023, 8:27 |
| Rights Offer results | 25 May 2023, 8:23 |
| Notice of change of exercise price of options | 22 May 2023, 8:25 |
| Despatch of Rights Offer documentation | 8 May 2023, 12:23 |
If you were already registered, log in here.
If you were already registered, log in here.